A rare genetic deletion in a blood group gene caused hemolytic disease of the fetus and newborn (HDFN) in twin infants.

In a recent study, parents of infants with HDFN reported feelings of uncertainty and distress regarding post-discharge care.

About one in three babies in Africa are born with anemia, a condition in which a baby’s blood doesn’t have enough healthy red ...

Fetal cfDNA testing can determine if a fetus lacks an antigen that could cause HDFN, avoiding further unnecessary tests and ...

Advancements in research and ongoing clinical trials related to HDFN prevention and treatment can change HDFN care for the better.

A study showed babies who have ABO-mediated HDFN should be checked for signs of jaundice two to three times during the first ...

Despite advances in screening and treatment, HDFN remains a significant cause of perinatal morbidity and mortality worldwide.

A pregnancy affected by HDFN due to rare antibodies was successfully managed, and the affected infant was born without serious complications.

A recent study found that phototherapy induces chemical changes to bilirubin that may lead to inaccurate and nonsensical measurements.

Hemolytic disease of the fetus and newborn (HDFN) is caused by a mismatch between the blood of a pregnant mother and her fetus. It occurs when the mother’s blood and the baby’s blood mix and the ...